期刊文献+

腹腔热灌注化疗联合静脉化疗治疗胃癌性恶性腹水的临床疗效分析 被引量:6

下载PDF
导出
摘要 目的探究腹腔热灌注化疗联合静脉化疗治疗胃癌性恶性腹水的临床疗效。方法本研究选取胃癌性恶性腹水患者76例,按照住院顺序分为两组,每组38例,对照组患者行化疗联合腹腔穿刺治疗,观察组患者行化疗联合腹腔热灌注治疗,比较两组患者临床疗效。结果对照组好转率为60.53%,观察组好转率为76.32%,差异明显(P<0.05)。结论腹腔热灌注化疗联合静脉化疗可改善胃癌性恶性腹水症状,提高临床疗效。
出处 《中国医药指南》 2017年第18期160-160,共1页 Guide of China Medicine
  • 相关文献

参考文献3

二级参考文献41

  • 1李安民.进展期胃癌根治术后腹腔热灌注化疗疗效评价[J].现代医药卫生,2007,23(17):2585-2585. 被引量:4
  • 2Barni S, Cabiddu M, Ghilardi M, Petrelli F. A novel perspective for an orphan problem: old and new drugs for the medical management of malignant as- cites. Crit Rev Oncol Hemato12011; 79:144-153 [PMID: 20708947 DOI: 10.1016/j.critrevonc.2010.0Z016].
  • 3Runyon BA. Care of patients with ascites. N Engl J Med 1994; 330:337-342 [PMID: 8277955 DOI: 10.1056/NEJM199402033300508].
  • 4N, Aslam Marino CR. Malignant ascites: new con- cepts in pathophysiology, diagnosis, and manage- ment. Arch Intern Med 2001; 161:2733-2737 [PMID: 11732940 DOI: 10.1001/archinte.161.22.27331.
  • 5Ayantunde AA, Parsons SL. Pattern and prognostic factors in patients with malignant ascites: a retro- spective study. Ann Oncol 2007; 18:945-949 [PMID: 17298959 DOI: 10.1093/annonc/md1499].
  • 6Wimberger P, Gilet I, Gonschior AK,Heiss MM, Moehler M, Oskay-Oezcelik G, A1-Batran SE, Schmalfeldt B, Schinittel A, Schulze E, Parsons SL. Deterioration in quality of life (QoL) in patients with malignant ascites: results from a phase II/ III study comparing paracentesis plus catumax- omab with paracentesis alone. Ann Oncol 2012; 23: 1979-1985 [PMID: 22734013 DOI: 10.1093/annonc/ rods178].
  • 7Becker G, Galandi D, Blum HE. Malignant ascites: systematic review and guideline for treatment. Eur J Cancer 2006; 42:589-597 [PMID: 16434188 DOI: 10.1016/j.ejca.2005.11.0181.
  • 8Cavazzoni E, Bugiantella W, Graziosi L, France- schini MS, Donini A. Malignant ascites: pathophysi ology and treatment. Int J Clin Oncol 2013; 18:1-9 [PMID: 22460778 DOI: 10.1007/s10147-012-0396-6].
  • 9Imamoto H, Oba K, Sakamoto J, Iishi H, Narahara H, Yumiba T, Morimoto T, Nakamura M, Oriuchi N, Kakutani C, Morita S, Shiozaki H. Assessing clinical benefit response in the treatment of gastric malig- nant ascites with non-measurable lesions: a multi- center phase II trial of paclitaxel for malignant asci- tes secondary to advanced/recurrent gastric cancer. Gastric Cancer 2011; 14:81-90 [PMID: 21327925 DOI: 10.1007/s10120-011-0016-6].
  • 10Jemal A, Bray F, Center MM, Ferlay J, Ward E, For- man D. Global cancer statistics. CA Cancer J Clin 2011; 61:69-90 [PMID: 21296855 DOI: 10.3322/ caac.201071.

共引文献28

同被引文献39

引证文献6

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部